Midcap Value Alert: 3 Years of Subscription at the Price of 1
Here is the latest financial fact sheet of VAISHALI PHARMA . For more details, see the VAISHALI PHARMA quarterly results and VAISHALI PHARMA share price.
1 Day | % | -0.3 |
No. of shares | m | 10.72 |
1 Week | % | 4.8 |
1 Month | % | 7.5 |
1 Year | % | 16.6 |
52 week H/L | Rs | 203.6/114.9 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
VAISHALI PHARMA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 60 | 49 | NA | 72 | 194 | |
Low | Rs | 40 | 24 | NA | 29 | 64 | |
Sales per share (Unadj.) | Rs | 113.9 | 57.0 | 51.0 | 71.9 | 66.0 | |
Earnings per share (Unadj.) | Rs | 1.1 | 0 | 1.0 | 3.8 | 6.3 | |
Diluted earnings per share | Rs | 0.7 | 0.0 | 1.0 | 3.8 | 6.2 | |
Cash flow per share (Unadj.) | Rs | 1.5 | 0.4 | 1.4 | 4.2 | 6.7 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 32.5 | 20.3 | 21.3 | 25.0 | 31.3 | |
Adj. book value per share | Rs | 20.0 | 19.9 | 20.9 | 24.6 | 30.8 | |
Shares outstanding (eoy) | m | 6.59 | 10.55 | 10.55 | 10.55 | 10.55 | |
Price / Sales ratio | x | 0.4 | 0.6 | 0 | 0.7 | 2.0 | |
Avg P/E ratio | x | 46.1 | 1,170.5 | 0 | 13.3 | 20.6 | |
P/CF ratio (eoy) | x | 33.5 | 81.3 | 0 | 11.9 | 19.1 | |
Price / Book Value ratio | x | 1.5 | 1.8 | 0 | 2.0 | 4.1 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 329 | 383 | 0 | 534 | 1,361 | |
Total wages/salary | Rs m | 21 | 13 | 12 | 14 | 13 |
VAISHALI PHARMA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 751 | 601 | 538 | 758 | 697 | |
Other income | Rs m | 20 | 22 | 18 | 18 | 22 | |
Total revenues | Rs m | 771 | 623 | 556 | 776 | 719 | |
Gross profit | Rs m | 21 | 9 | 26 | 69 | 94 | |
Depreciation | Rs m | 3 | 4 | 4 | 5 | 5 | |
Interest | Rs m | 27 | 26 | 26 | 25 | 23 | |
Profit before tax | Rs m | 11 | 1 | 14 | 57 | 88 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 4 | 0 | 4 | 17 | 22 | |
Profit after tax | Rs m | 7 | 0 | 10 | 40 | 66 | |
Gross profit margin | % | 2.8 | 1.5 | 4.9 | 9.1 | 13.5 | |
Effective tax rate | % | 37.0 | 58.6 | 25.5 | 29.8 | 25.4 | |
Net profit margin | % | 1.0 | 0.1 | 1.9 | 5.3 | 9.5 |
VAISHALI PHARMA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 630 | 612 | 813 | 764 | 727 | |
Current liabilities | Rs m | 425 | 404 | 593 | 519 | 321 | |
Net working cap to sales | % | 27.3 | 34.6 | 41.0 | 32.3 | 58.3 | |
Current ratio | x | 1.5 | 1.5 | 1.4 | 1.5 | 2.3 | |
Inventory Days | Days | 21 | 20 | 23 | 16 | 18 | |
Debtors Days | Days | 240,236,955 | 285,684,199 | 452,945,946 | 2,816 | 2,809 | |
Net fixed assets | Rs m | 57 | 49 | 47 | 50 | 61 | |
Share capital | Rs m | 66 | 105 | 105 | 105 | 105 | |
"Free" reserves | Rs m | 148 | 108 | 119 | 158 | 224 | |
Net worth | Rs m | 214 | 214 | 224 | 264 | 330 | |
Long term debt | Rs m | 48 | 41 | 40 | 31 | 52 | |
Total assets | Rs m | 686 | 661 | 860 | 815 | 788 | |
Interest coverage | x | 1.4 | 1.0 | 1.5 | 3.3 | 4.9 | |
Debt to equity ratio | x | 0.2 | 0.2 | 0.2 | 0.1 | 0.2 | |
Sales to assets ratio | x | 1.1 | 0.9 | 0.6 | 0.9 | 0.9 | |
Return on assets | % | 4.9 | 3.9 | 4.3 | 8.0 | 11.2 | |
Return on equity | % | 3.3 | 0.2 | 4.7 | 15.3 | 20.0 | |
Return on capital | % | 14.5 | 10.4 | 15.2 | 27.9 | 29.1 | |
Exports to sales | % | 18.7 | 21.7 | 16.7 | 18.3 | 25.2 | |
Imports to sales | % | 0 | 0 | 0 | 5.2 | 7.8 | |
Exports (fob) | Rs m | 140 | 130 | 90 | 138 | 176 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 39 | 54 | |
Fx inflow | Rs m | 140 | 130 | 90 | 138 | 176 | |
Fx outflow | Rs m | 2 | 2 | 0 | 41 | 55 | |
Net fx | Rs m | 138 | 128 | 90 | 98 | 121 |
VAISHALI PHARMA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 43 | 32 | 20 | 13 | 11 | |
From Investments | Rs m | -3 | -0 | -1 | -8 | 3 | |
From Financial Activity | Rs m | -40 | -31 | -18 | 4 | -17 | |
Net Cashflow | Rs m | 0 | 1 | 1 | 9 | -4 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Atul Vasani | COMP SEC: Akshay Jharkhandi | YEAR OF INC: 2008 | NSE CODE: 563147895 | FV (Rs): 10 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: ADANI PORTS & SEZ ADANI ENTERPRISES ZOMATO APOLLO HOSPITALS ADANI TOTAL GAS
Compare VAISHALI PHARMA With: ADANI PORTS & SEZ ADANI ENTERPRISES ZOMATO APOLLO HOSPITALS ADANI TOTAL GAS
Asian share markets made a cautious start on Monday in a week where inflation figures could make or break hopes for earlier US rate cuts.